Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

47 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The neuropeptide catestatin acts as a novel angiogenic cytokine via a basic fibroblast growth factor-dependent mechanism.
Theurl M, Schgoer W, Albrecht K, Jeschke J, Egger M, Beer AG, Vasiljevic D, Rong S, Wolf AM, Bahlmann FH, Patsch JR, Wolf D, Schratzberger P, Mahata SK, Kirchmair R. Theurl M, et al. Among authors: bahlmann fh. Circ Res. 2010 Nov 26;107(11):1326-35. doi: 10.1161/CIRCRESAHA.110.219493. Epub 2010 Oct 7. Circ Res. 2010. PMID: 20930149 Free PMC article.
Gene therapy with the angiogenic cytokine secretoneurin induces therapeutic angiogenesis by a nitric oxide-dependent mechanism.
Schgoer W, Theurl M, Jeschke J, Beer AG, Albrecht K, Gander R, Rong S, Vasiljevic D, Egger M, Wolf AM, Frauscher S, Koller B, Tancevski I, Patsch JR, Schratzberger P, Piza-Katzer H, Ritsch A, Bahlmann FH, Fischer-Colbrie R, Wolf D, Kirchmair R. Schgoer W, et al. Among authors: bahlmann fh. Circ Res. 2009 Nov 6;105(10):994-1002. doi: 10.1161/CIRCRESAHA.109.199513. Epub 2009 Oct 1. Circ Res. 2009. PMID: 19797703
Antiangiogenesis mediates cisplatin-induced peripheral neuropathy: attenuation or reversal by local vascular endothelial growth factor gene therapy without augmenting tumor growth.
Kirchmair R, Walter DH, Ii M, Rittig K, Tietz AB, Murayama T, Emanueli C, Silver M, Wecker A, Amant C, Schratzberger P, Yoon YS, Weber A, Panagiotou E, Rosen KM, Bahlmann FH, Adelman LS, Weinberg DH, Ropper AH, Isner JM, Losordo DW. Kirchmair R, et al. Among authors: bahlmann fh. Circulation. 2005 May 24;111(20):2662-70. doi: 10.1161/CIRCULATIONAHA.104.470849. Epub 2005 May 16. Circulation. 2005. PMID: 15897348
Low-dose therapy with the long-acting erythropoietin analogue darbepoetin alpha persistently activates endothelial Akt and attenuates progressive organ failure.
Bahlmann FH, Song R, Boehm SM, Mengel M, von Wasielewski R, Lindschau C, Kirsch T, de Groot K, Laudeley R, Niemczyk E, Güler F, Menne J, Haller H, Fliser D. Bahlmann FH, et al. Circulation. 2004 Aug 24;110(8):1006-12. doi: 10.1161/01.CIR.0000139335.04152.F3. Epub 2004 Aug 9. Circulation. 2004. PMID: 15302785
Reversal of experimental diabetic neuropathy by VEGF gene transfer.
Schratzberger P, Walter DH, Rittig K, Bahlmann FH, Pola R, Curry C, Silver M, Krainin JG, Weinberg DH, Ropper AH, Isner JM. Schratzberger P, et al. Among authors: bahlmann fh. J Clin Invest. 2001 May;107(9):1083-92. doi: 10.1172/JCI12188. J Clin Invest. 2001. PMID: 11342572 Free PMC article.
Oxidant stress impairs in vivo reendothelialization capacity of endothelial progenitor cells from patients with type 2 diabetes mellitus: restoration by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone.
Sorrentino SA, Bahlmann FH, Besler C, Müller M, Schulz S, Kirchhoff N, Doerries C, Horváth T, Limbourg A, Limbourg F, Fliser D, Haller H, Drexler H, Landmesser U. Sorrentino SA, et al. Among authors: bahlmann fh. Circulation. 2007 Jul 10;116(2):163-73. doi: 10.1161/CIRCULATIONAHA.106.684381. Epub 2007 Jun 25. Circulation. 2007. PMID: 17592079
Erythropoietin regulates endothelial progenitor cells.
Bahlmann FH, De Groot K, Spandau JM, Landry AL, Hertel B, Duckert T, Boehm SM, Menne J, Haller H, Fliser D. Bahlmann FH, et al. Blood. 2004 Feb 1;103(3):921-6. doi: 10.1182/blood-2003-04-1284. Epub 2003 Oct 2. Blood. 2004. PMID: 14525788 Free article.
Endothelial-vasoprotective effects of high-density lipoprotein are impaired in patients with type 2 diabetes mellitus but are improved after extended-release niacin therapy.
Sorrentino SA, Besler C, Rohrer L, Meyer M, Heinrich K, Bahlmann FH, Mueller M, Horváth T, Doerries C, Heinemann M, Flemmer S, Markowski A, Manes C, Bahr MJ, Haller H, von Eckardstein A, Drexler H, Landmesser U. Sorrentino SA, et al. Among authors: bahlmann fh. Circulation. 2010 Jan 5;121(1):110-22. doi: 10.1161/CIRCULATIONAHA.108.836346. Epub 2009 Dec 21. Circulation. 2010. PMID: 20026785 Free article. Clinical Trial.
47 results